Mabwell (Shanghai) Bioscience Co., Ltd. (SHA:688062)
China flag China · Delayed Price · Currency is CNY
35.98
-1.22 (-3.28%)
May 12, 2026, 3:00 PM CST

SHA:688062 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,4861,5281,1931,6512,49196.54
Short-Term Investments
--35.8735.26--
Trading Asset Securities
3.52-3.7714.8860.12-
Cash & Short-Term Investments
1,4891,5281,2321,7012,55196.54
Cash Growth
31.81%24.02%-27.56%-33.32%2542.47%-82.38%
Accounts Receivable
127.5299.7938.3417.510.070.14
Other Receivables
126.11123.3100.05112.2782.6533.01
Receivables
253.63223.09138.39129.7882.7333.15
Inventory
197.92187.9211.68159.379.0540.11
Other Current Assets
172.0999.33122.8457.4865.1274.93
Total Current Assets
2,1132,0391,7052,0482,778244.74
Property, Plant & Equipment
1,9011,9702,0531,9351,263811.64
Long-Term Investments
88.9791.1446.6641.9520.218.95
Goodwill
118.77118.77118.77118.77118.77118.77
Other Intangible Assets
144.95146.06152.81139.72161.31179.4
Long-Term Deferred Charges
5.836.266.390.986.1312.71
Other Long-Term Assets
196.52184.69192.76170.98271.93209.07
Total Assets
4,5684,5564,2764,4554,6191,595
Accounts Payable
150.98197.38100.2362.3245.2139.69
Accrued Expenses
97.72145.03150.64138.1282.2557.53
Short-Term Debt
1,3531,147921.6209.27100.1410.82
Current Portion of Long-Term Debt
301.98183.8113.651.590.60.15
Current Portion of Leases
-134.4131.5226.9621.0218.83
Current Income Taxes Payable
19.742.342.393.34--
Current Unearned Revenue
303.52288.5936.0113.5236.6563.53
Other Current Liabilities
184.77160.38185.67361.26159.2779.85
Total Current Liabilities
2,4122,2591,542816.39445.14270.41
Long-Term Debt
1,4551,3411,006887.72492.12132.05
Long-Term Leases
155.56165.94142.97167.11160.57172.72
Long-Term Unearned Revenue
27.4549.1927.0710.5911.0311.47
Other Long-Term Liabilities
229.52208.121.53---
Total Liabilities
4,2794,0232,7201,8821,109586.65
Common Stock
399.6399.6399.6399.6399.6299.7
Additional Paid-In Capital
-5,7605,9595,9315,8122,456
Retained Earnings
-6,007-5,765-4,795-3,751-2,698-1,743
Treasury Stock
-49.99-49.99----
Comprehensive Income & Other
5,7644.455.084.81.56-2.6
Total Common Equity
106.82349.511,5692,5843,5161,011
Minority Interest
182.4183.5-13.1-10.45-5.08-2.18
Shareholders' Equity
289.215331,5562,5733,5111,009
Total Liabilities & Equity
4,5684,5564,2764,4554,6191,595
Total Debt
3,2652,9722,2161,293774.45334.58
Net Cash (Debt)
-1,776-1,444-983.91408.41,777-238.03
Net Cash Growth
----77.01%--
Net Cash Per Share
-4.46-3.62-2.461.024.54-0.79
Filing Date Shares Outstanding
398.41398.41399.6399.6399.6299.7
Total Common Shares Outstanding
398.41398.41399.6399.6399.6299.7
Working Capital
-299.1-220163.471,2312,333-25.68
Book Value Per Share
0.270.883.936.478.803.37
Tangible Book Value
-156.984.681,2972,3253,236712.64
Tangible Book Value Per Share
-0.390.213.255.828.102.38
Buildings
-754.31753.02181.833.063.06
Machinery
-1,2211,206653.69440.39420.08
Construction In Progress
-348.36240.871,131804.49313.24
Source: S&P Global Market Intelligence. Standard template. Financial Sources.